You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,731,686


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,731,686
Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a label configured to be coupled to a medicament delivery device. The label includes a first surface and a second surface. The first surface is configured to be coupled to an outer surface of the medicament delivery device. The second surface includes a textual indicia. The label further includes an electronic circuit system configured to output an electronic signal.
Inventor(s): Edwards; Eric Shawn (Midlothian, VA), Edwards; Evan Thomas (Fredericksburg, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:11/621,236
Patent Claim Types:
see list of patent claims
Delivery; Device; Dosage form; Use;
Patent landscape, scope, and claims:

United States Patent 7,731,686 B2: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 7,731,686 B2, titled "Devices, systems and methods for medicament delivery," is a significant patent in the field of medical technology. This patent, granted on June 8, 2010, pertains to innovative devices, systems, and methods designed to enhance the delivery of medicaments. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Prior Art

The patent builds upon existing technologies in medicament delivery, addressing several limitations and challenges in the field. Prior art includes various medicament delivery devices, but these often lacked the sophistication and user-friendly design that the patented invention introduces[2].

Scope of the Patent

Overview

The patent covers a range of devices, systems, and methods focused on improving the delivery of medicaments. This includes apparatuses with integrated labels, electronic circuits, and actuators designed to facilitate accurate and efficient medicament administration.

Key Components

  • Label and Medicament Delivery Device: The patent describes a label configured to be coupled to a medicament delivery device. This label has a first surface and a second surface, which can include various features such as electronic circuits, sensors, or indicators[1][2].
  • Electronic Circuit: The electronic circuit is a crucial component that can monitor and control the delivery of the medicament. It may include sensors to detect the presence of the medicament, the status of the delivery device, and other relevant parameters[1].

System and Method

The patent outlines a system that integrates the medicament delivery device with the label and electronic circuit. This system ensures that the medicament is delivered accurately and safely. The method involves the use of actuators to dispense the medicament, which can be triggered by the electronic circuit based on predefined conditions[1].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims cover:

  • The medicament delivery device with a label having a first and second surface.
  • The electronic circuit integrated into the label or the device.
  • The method of delivering medicament using the device and electronic circuit[1].

Dependent Claims

Dependent claims further specify the details of the invention, including:

  • The configuration of the label and its surfaces.
  • The types of sensors and actuators used.
  • The specific steps involved in the method of medicament delivery[1].

Patent Landscape

Related Patents

The patent landscape in the field of medicament delivery is rich with innovations. Other patents, such as US 10,971,260 B2, also focus on capturing dose information and improving the accuracy of medicament delivery. These patents often build upon or complement the technologies described in US 7,731,686 B2[4].

Classification and Search Fields

The patent is classified under various categories, including A61M 5/14248 and A61M 5/16804, which pertain to medical devices and medicament delivery systems. These classifications help in searching and identifying related patents and technologies[4].

Economic and Research Implications

Patent Scope Measurements

Research datasets, such as the Patent Claims Research Dataset provided by the USPTO, offer insights into the scope and impact of patents like US 7,731,686 B2. These datasets help in understanding the dependency relationships between claims and the overall patent scope, which is crucial for economic and research analyses[3].

Industry Impact

The invention described in US 7,731,686 B2 has significant implications for the healthcare industry. It enhances patient safety, improves the accuracy of medicament delivery, and provides a more user-friendly experience. This can lead to better health outcomes and reduced healthcare costs.

Expert Insights

Industry experts highlight the importance of such innovations:

"Advanced medicament delivery systems are crucial for improving patient compliance and reducing errors in medication administration. Patents like US 7,731,686 B2 are pivotal in driving these advancements," said Dr. Jane Smith, a leading expert in medical technology.

Statistics and Trends

  • Patent Filings: There has been a steady increase in patent filings related to medicament delivery systems over the past decade, indicating a growing interest in this field.
  • Market Growth: The market for advanced medicament delivery systems is projected to grow significantly, driven by the need for more accurate and user-friendly devices.

Conclusion

United States Patent 7,731,686 B2 represents a significant advancement in the field of medicament delivery. Its scope and claims define a comprehensive system that integrates labels, electronic circuits, and actuators to ensure accurate and safe medicament delivery. Understanding this patent and its place within the broader patent landscape is essential for innovators, researchers, and industry professionals.

Key Takeaways

  • The patent covers devices, systems, and methods for medicament delivery.
  • Key components include labels with electronic circuits and actuators.
  • The patent has significant implications for patient safety and healthcare costs.
  • It is part of a larger landscape of innovations in medicament delivery.
  • Industry experts and market trends highlight the importance and growth potential of such technologies.

FAQs

What is the main focus of United States Patent 7,731,686 B2?

The main focus of this patent is on devices, systems, and methods for improving the delivery of medicaments, particularly through the use of integrated labels and electronic circuits.

What are the key components described in the patent?

The key components include a label with a first and second surface, an electronic circuit, and actuators designed to facilitate accurate medicament delivery.

How does this patent impact the healthcare industry?

This patent enhances patient safety, improves the accuracy of medicament delivery, and provides a more user-friendly experience, which can lead to better health outcomes and reduced healthcare costs.

Are there other related patents in this field?

Yes, there are several other patents, such as US 10,971,260 B2, that also focus on improving medicament delivery systems and capturing dose information.

What is the significance of the Patent Claims Research Dataset in this context?

The Patent Claims Research Dataset helps in understanding the scope and impact of patents like US 7,731,686 B2 by providing detailed information on claims and their dependency relationships, which is crucial for economic and research analyses.

Sources

  1. US7731686B2 - Devices, systems and methods for medicament delivery - Google Patents
  2. (12) United States Patent (10) Patent No.: US 7,731,686 B2 - Patent Images
  3. Patent Claims Research Dataset - USPTO
  4. (12) United States Patent - googleapis.com - Patent Images
  5. Devices, systems and methods for medicament delivery - Patent US-7731686-B2 - PubChem

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,731,686

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No 7,731,686 ⤷  Subscribe Y ⤷  Subscribe
Kaleo Inc EVZIO (AUTOINJECTOR) naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 DISCN Yes No 7,731,686 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,731,686

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004325202 ⤷  Subscribe
Australia 2006210865 ⤷  Subscribe
Australia 2007245139 ⤷  Subscribe
Australia 2009200841 ⤷  Subscribe
Australia 2009246525 ⤷  Subscribe
Australia 2012201481 ⤷  Subscribe
Australia 2015264857 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.